McKesson, US58155Q1031

McKesson stock: Mizuho raises target to USD 1,020

Published on 10/22/2026 at 17:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson reports second-quarter results on November 4, 2026. McKesson stock costs EUR 903.60 on October 22, 2026 at 5:45 p.m. CEST.

Target and trading facts

  • Mizuho lifted its McKesson target from USD 905.00 to USD 1,020.00 on October 20, 2026.
  • McKesson will release second-quarter fiscal 2027 results on November 4, 2026.
  • McKesson stock costs EUR 903.60 at Lang & Schwarz on October 22, 2026 at 5:45 p.m. CEST.
Bauhaus-Poster mit geometrischen Formen und Schriftzug PHARMA repräsentiert die Branche von McKesson Corporation ISIN US58155Q1031, Illustration mit AI erstellt.

McKesson Corporation (US58155Q1031) is facing a higher valuation bar after Mizuho raised its price target from USD 905.00 to USD 1,020.00 on October 20, 2026, while keeping a neutral rating, MarketBeat reported. McKesson stock was trading at EUR 903.60 at Lang & Schwarz on October 22, 2026 at 5:45 p.m. CEST.

Mizuho raises the valuation bar

The new Mizuho target stands 0.81 percent above McKesson's USD 1,011.80 primary-market price at 11:51 a.m. ET on October 22, 2026. The target revision therefore points to a narrow gap at the latest quoted level, while the neutral rating provides a counterweight to the higher numerical target.

Results date adds a near-term test

McKesson will release second-quarter fiscal 2027 results after the market closes on November 4, 2026, and will hold its investor conference call at 4:30 p.m. ET, according to the company's announcement dated September 23, 2026, McKesson. The scheduled release is the next dated event for investors.

Price position and valuation

McKesson's primary-market quote was USD 1,011.80, down 0.36 percent from the previous session's USD 1,015.50 at the latest intraday timestamp. The stock's 52-week range was USD 723.68 to USD 1,030.27, putting the latest quote 1.79 percent below the high and 39.81 percent above the low.

The company carried a market capitalization of USD 118.0 billion on October 22, 2026, with a price-to-earnings ratio of 27.05. Its latest reported first-quarter fiscal 2027 revenue was USD 105.38 billion and net income attributable to common shareholders was USD 614.00 million for the period ended June 30, 2026.

What comes next for McKesson

The immediate question is whether the November results can support the target revision with fresh operating evidence. Mizuho's USD 1,020.00 target, the USD 118.0 billion market value and the November 4 reporting date give investors three dated reference points for assessing the next update.

Trading view

The after-hours euro quote places McKesson at EUR 903.60 at Lang & Schwarz on October 22, 2026 at 5:45 p.m. CEST. The primary-market quote was USD 1,011.80 on the NYSE at 11:51 a.m. ET on the same date.

The further course of trading is shown by the continuously updated real-time quote of McKesson stock.

McKesson stock facts

  • Company: McKesson Corporation
  • ISIN: US58155Q1031
  • Ticker: MCK
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 22, 2026, 5:45 p.m. CEST): EUR 903.60
  • Market capitalization: USD 118.0 billion (as of October 22, 2026)
  • 52-week range: USD 723.68-1,030.27
  • Sector / Industry: Healthcare / Medical distribution
  • Next earnings date: November 4, 2026

Market context: Market report S&P 500.

More news and analyses on McKesson stock

Disclaimer...
en | US58155Q1031 | MCKESSON | boerse | 70394685 | bgmi